SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW) -- Ignore unavailable to you. Want to Upgrade?


To: Stock Watcher who wrote (35204)6/27/2000 1:40:00 PM
From: Chad Beemer  Read Replies (1) | Respond to of 52051
 
I agree Stockwatcher

ZAND should see continued accumulation and volume as it gets closer to the 15th. Traders are content to have fun for now
but I think continuing pressure of accumulation will force there hand.



To: Stock Watcher who wrote (35204)6/27/2000 1:43:00 PM
From: DENNIS TULLY  Read Replies (2) | Respond to of 52051
 
COII

IMO - This is just the beginning!!!

Talk about a great NEWS DAY:

*******COII RECEIVES NASDAQ APPROVAL*********
Computerized Thermal Imaging, Inc. Receives Approval to be Listed on Nasdaq
LAYTON, Utah, Jun 27, 2000 (BUSINESS WIRE) -- Computerized Thermal Imaging, Inc. (OTCBB symbol: COII chart, msgs) announced today that its stock has been approved for listing on the Nasdaq National Market. The Company's common stock will continue to trade under the symbol COII. The Company anticipates that trading of its common stock on Nasdaq will begin on June 29, 2000.

"Our move to Nasdaq is a milestone that recognizes our continued growth and maturity and provides our more than 28,000 shareholders with a broader and more stable market environment. We are particularly pleased to make this announcement in connection with our stockholders meeting," stated David Packer, CTI president. "We believe that this move opens our doors to institutional investors that have heretofore remained on the sidelines and provides access to the capital markets to move us beyond the development stage."

CTI is seeking FDA approval for the use of the Computerized Thermal Imaging System as an adjunctive diagnostic test to the mammogram and clinical examination for the detection of breast cancer. The test is simple, painless and involves no radiation, breast compression, electrodes, electrical current or skin contact. CTI also recently announced the evaluation of their technology for new occupational medicine applications.

Computerized Thermal Imaging, Inc. is in business to improve the quality of life through superior diagnostics. Information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 926-1113.

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC.